Literature DB >> 11986097

Corneally displaced malignant conjunctival melanomas.

Seppo Tuomaala1, Esko Aine, K Matti Saari, Tero Kivelä.   

Abstract

PURPOSE: To characterize and classify malignant conjunctival melanomas with exclusively corneal invasive growth.
DESIGN: Population-based, nationwide retrospective cross-sectional study. PARTICIPANTS: Patients with primary malignant conjunctival melanoma diagnosed between 1967 and 2000 in Finland.
METHODS: On the basis of all available clinical and histopathologic data of tumors diagnosed during the study period, malignant conjunctival melanomas that first demonstrated invasive growth on the cornea without evidence of conjunctival tumors other than primary acquired melanosis were identified, their prevalence calculated, and their characteristics reviewed. On the basis of these cases and literature data, a classification for "corneal melanoma" was developed. MAIN OUTCOME MEASURES: Frequency and type of corneal involvement, recurrence, and survival.
RESULTS: Patients with exclusively corneal invasive tumor accounted for 5% (95% confidence interval, 1-12) of 85 consecutive primary conjunctival melanomas. Two were separated from the limbus by clear cornea (type I), and two paralleled but did not invade the limbal conjunctiva (type II). Two were associated with clear evidence of primary acquired melanosis. None of the tumors recurred after local excision, and no metastases were observed during a median follow-up of 2 years 5 months (range, 1 year 8 months-7 years 10 months).
CONCLUSIONS: Primary malignant conjunctival melanomas can grow on the cornea without conjunctival involvement other than acquired melanosis. They are easily removed and do not cause lymphatic metastases. The term "corneally displaced malignant conjunctival melanoma" would best describe their supposed conjunctival origin and actual corneal location.

Entities:  

Mesh:

Year:  2002        PMID: 11986097     DOI: 10.1016/s0161-6420(02)00967-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Invasive malignant melanoma of the cornea after industrial injury.

Authors:  Saqib Ali Khan Utman; J Nigel James; Karen L Ramsden; Hanna Masud Baig
Journal:  Int Ophthalmol       Date:  2013-03-26       Impact factor: 2.031

Review 2.  Advances in the management of conjunctival melanoma.

Authors:  Gargi K Vora; Hakan Demirci; Brian Marr; Prithvi Mruthyunjaya
Journal:  Surv Ophthalmol       Date:  2016-06-16       Impact factor: 6.048

3.  Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions.

Authors:  Simone Nuessle; Claudia Auw-Haedrich; Jana Jiang; Daniel Boehringer; Thomas Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-18       Impact factor: 3.535

Review 4.  Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond.

Authors:  T Kivelä; E Kujala
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

Review 5.  Conjunctival melanoma and melanocytic intra-epithelial neoplasia.

Authors:  N Kenawy; S L Lake; S E Coupland; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

6.  [Malignant melanoma of the cornea after blunt trauma].

Authors:  T Jukić; D Katusic; R Kordić; M Cacić; T Braunschweig; G Thumann
Journal:  Ophthalmologe       Date:  2009-07       Impact factor: 1.059

7.  Brown cornea.

Authors:  Zita Steiber; Niels Ehlers; Steffen Heegaard; Jesper Hjortdal; Andras Berta; Jan Ulrik Prause
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-12       Impact factor: 3.117

8.  Clinical and Histopathological Features of Corneal Primary Acquired Melanosis and Melanoma.

Authors:  Aaron Yeung; Ogul E Uner; Jill R Wells; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2021-01-21

Review 9.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.